Epigenetic Approaches: Emerging Role of Histone Deacetylase Inhibitors in Cancer Immunotherapy

Keyphrases

• In Cancer 100%
• Histone Deacetylase Inhibitor (HDACi) 100%
• Cancer Immunotherapy 100%
• Epigenetics 100%
• Histone Deacetylases 100%
• Cell Biology 20%
• Clinically Significant 20%
• Malignancy 20%
• Tumor Cells 20%
• Anti-inflammatory Effect 20%
• Antitumor Activity 20%
• Antitumor Immune Response 20%
• Regulatory Function 20%
• Immune Cells 20%
• Apoptosis 20%
• Histone 20%
• Less Toxic 20%
• Immunobiology 20%
• Inflammatory Effects 20%
• Cell Cycle Arrest 20%
• Gene Promoter 20%
• Deacetylate 20%
• Immunomodulatory Properties 20%
• Cell Effects 20%
• Histone Modification 20%
• Immunoregulatory Effect 20%
• Non-histone Protein 20%

Immunology and Microbiology

• Cancer Immunotherapy 100%
• Histone 100%
• Immunology 10%
• Immune Response 10%
• Antineoplastic Activity 10%
• Immunocompetent Cell 10%
• Tumor Cell 10%
• Cell Cycle Arrest 10%
• Antiinflammatory Activity 10%
• Cell Cycle Checkpoint 10%
• Programmed Cell Death 10%
• Gene Promoter 10%
• Histone Modification 10%
• Cytotechnology 10%
• Cytology 10%
• Cell Biology 10%
• In Vitro 10%

Biochemistry, Genetics and Molecular Biology

• Histone Deacetylase 100%
• Cancer Immunotherapy 100%
• In Vivo Study 11%
• Transcription 11%
• Gene Promoter 11%
• Histone Modification 11%
• Enzyme 11%
• Immunocompetent Cell 11%
• Immune Response 11%
• Antiinflammatory Activity 11%
• Cell Cycle Arrest 11%
• Antineoplastic Activity 11%
• Cell Cycle Checkpoint 11%
• Histone 11%
• Programmed Cell Death 11%